SE466654B - Biologiskt aktiva 2,5-piperazindionderivat, saett foer framstaellning daerav samt farmaceutiska kompositioner innehaallande desamma - Google Patents

Biologiskt aktiva 2,5-piperazindionderivat, saett foer framstaellning daerav samt farmaceutiska kompositioner innehaallande desamma

Info

Publication number
SE466654B
SE466654B SE8305157A SE8305157A SE466654B SE 466654 B SE466654 B SE 466654B SE 8305157 A SE8305157 A SE 8305157A SE 8305157 A SE8305157 A SE 8305157A SE 466654 B SE466654 B SE 466654B
Authority
SE
Sweden
Prior art keywords
compound
formula
amino
group
cyclo
Prior art date
Application number
SE8305157A
Other languages
English (en)
Swedish (sv)
Other versions
SE8305157L (sv
SE8305157D0 (sv
Inventor
E Kasafirek
J Vanzura
I Krejci
J Krepelka
A Dlabac
M Valchar
Original Assignee
Spofa Vereinigte Pharma Werke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spofa Vereinigte Pharma Werke filed Critical Spofa Vereinigte Pharma Werke
Publication of SE8305157D0 publication Critical patent/SE8305157D0/xx
Publication of SE8305157L publication Critical patent/SE8305157L/xx
Publication of SE466654B publication Critical patent/SE466654B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE8305157A 1982-10-01 1983-09-23 Biologiskt aktiva 2,5-piperazindionderivat, saett foer framstaellning daerav samt farmaceutiska kompositioner innehaallande desamma SE466654B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS827012A CS231227B1 (en) 1982-10-01 1982-10-01 2,5-pierazindion derivatives

Publications (3)

Publication Number Publication Date
SE8305157D0 SE8305157D0 (sv) 1983-09-23
SE8305157L SE8305157L (sv) 1984-04-02
SE466654B true SE466654B (sv) 1992-03-16

Family

ID=5418454

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8305157A SE466654B (sv) 1982-10-01 1983-09-23 Biologiskt aktiva 2,5-piperazindionderivat, saett foer framstaellning daerav samt farmaceutiska kompositioner innehaallande desamma

Country Status (12)

Country Link
JP (1) JPS5989671A (xx)
AT (1) AT388161B (xx)
BE (1) BE897843A (xx)
CH (1) CH655929A5 (xx)
CS (1) CS231227B1 (xx)
DE (1) DE3335891C2 (xx)
FR (1) FR2533919B1 (xx)
GB (1) GB2127807B (xx)
HU (1) HU193047B (xx)
IT (1) IT1171091B (xx)
SE (1) SE466654B (xx)
YU (1) YU44751B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS277405B6 (en) * 1986-06-12 1993-03-17 Vyzk Ustav Farm Biochem Sp Peptides with 1-amino-1-cycloalkane carboxylic acid
US5182285A (en) * 1986-11-07 1993-01-26 Spojene Podniky Pro Zdravotnickou Vyrobu Cell-protective composition for preventing or treating of peptic ulcer
GB8822674D0 (en) * 1988-09-27 1988-11-02 Tate & Lyle Plc Preparation of acylated sucrose derivatives
US7202279B1 (en) * 1998-02-11 2007-04-10 Georgetown University Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders
AU780419C (en) * 1999-12-03 2005-09-29 Ono Pharmaceutical Co. Ltd. Triazaspiro(5.5)undecane derivatives and drugs containing the same as the active ingredient
CN1533390A (zh) 2001-03-19 2004-09-29 СҰҩƷ��ҵ��ʽ���� 包含三氮杂螺[5.5]十一烷衍生物作为活性成分的药物组合物
JP4047365B2 (ja) 2006-01-11 2008-02-13 生化学工業株式会社 シクロアルカンカルボキサミド誘導体及びその製造方法
AU2007205578B2 (en) * 2006-01-11 2012-06-28 Seikagaku Corporation Cycloalkylcarbonylamino acid ester derivative and process for producing the same
JP3975226B2 (ja) 2006-01-11 2007-09-12 生化学工業株式会社 シクロアルキルカルボニルアミノ酸誘導体及びその製造方法
WO2013020527A1 (en) 2011-08-11 2013-02-14 University Of Veterinary And Pharmaceutical Sciences Brno Faculty Of Pharmacy Utilization of alaptide as transdermal penetration modifier in pharmaceutical compositions for human and veterinary applications containing anti-inflammatory drugs and/or antimicrobial chemotherapeutics
WO2014019556A1 (en) 2012-08-02 2014-02-06 University Of Veterinary And Pharmaceutical Sciences Brno Faculty Of Pharmacy Alaptide : methods of effecting its solubility, membrane permeation and pharmaceutical compositions for human and/or veterinary applications
CN107903303B (zh) * 2017-11-20 2021-06-04 陕西慧康生物科技有限责任公司 一种环肽Alaptide的液相合成方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1459488A (en) * 1974-03-19 1976-12-22 Wyeth John & Brother Ltd Piperazinedione derivatives

Also Published As

Publication number Publication date
CS701282A1 (en) 1984-01-16
IT1171091B (it) 1987-06-10
SE8305157L (sv) 1984-04-02
JPH0526782B2 (xx) 1993-04-19
BE897843A (fr) 1984-01-16
SE8305157D0 (sv) 1983-09-23
GB8324683D0 (en) 1983-10-19
DE3335891C2 (de) 1993-11-11
CS231227B1 (en) 1984-10-15
FR2533919A1 (fr) 1984-04-06
IT8323058A1 (it) 1985-03-29
IT8323058A0 (it) 1983-09-29
GB2127807B (en) 1987-02-25
CH655929A5 (de) 1986-05-30
ATA336683A (de) 1988-10-15
JPS5989671A (ja) 1984-05-23
GB2127807A (en) 1984-04-18
AT388161B (de) 1989-05-10
DE3335891A1 (de) 1984-04-05
FR2533919B1 (fr) 1986-10-03
YU44751B (en) 1991-02-28
YU195283A (en) 1986-10-31
HU193047B (en) 1987-08-28

Similar Documents

Publication Publication Date Title
EP0462884B1 (fr) Dérivés de TRH, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
AU695021B2 (en) PF1022 derivative cyclic depsipeptide
EP0123444B1 (en) 4-substituted-2-azetidinone compound, process of producing the compounds, and medicaments containing the compounds
SE466654B (sv) Biologiskt aktiva 2,5-piperazindionderivat, saett foer framstaellning daerav samt farmaceutiska kompositioner innehaallande desamma
CH650519A5 (de) Auf das zentrale nervensystem wirkende tripeptide und verfahren zur herstellung derselben.
FI61188B (fi) Foerfarande foer framstaellning av 8alfa-syanometylergolin-i-foereningar med dopaminergisk och prolaktinsekretionshaemmande verkan
HU203766B (en) Process for producing estramustine-esters and pharmaceutical compositions containing them as active components
CS227035B2 (en) Method of preparing 1-(3-hydroxy-4-methoxyonzoyl)-3-hydroxy-2-pyrrolidinone
CA1202317A (en) Acetylsalicylic acid thioesters, a process for their preparation and pharmaceutical compositions containing them
EP0228625B1 (de) Peptid-Derivate mit inhibitorischer Wirkung auf hydroxylierende Enzyme, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und ihre Verwendung
SU1356959A3 (ru) Способ получени кристаллического (4,5,6R,8R)метилового эфира 9-оксо-11 @ ,15 @ -Дигидрокси-16-фенокси-17,18,19,20-тетранорпроста-4,5,13/Е/-триеновой кислоты
EP0271443B1 (de) N,N'-Disubstituierte Harnstoffe und Verfahren zu ihrer Herstellung
US4405607A (en) Novel pentapeptides, processes for their production, pharmaceutical compositions comprising said pentapeptides and their use
IE42784B1 (en) Tripeptides
US3681355A (en) Ergonarcarnines
US4235895A (en) Substituted 5H-dibenz[b,f]azepine
SE447262B (sv) Analogiforfarande for framstellning av en undekapeptid med immunopotentierande egenskaper
EP0069894B1 (de) Optisch aktives Dipeptide, seine pharmazeutisch verträglichen Salze, Verfahren zur Herstellung und diese enthaltende pharmazeutische Präparate
FI61687B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara alfa-metyl-3,4-dihydroxifenylalaninderivat
SE455097B (sv) Peptidergotalkaloider, forfarande for deras framstellning och farmaceutisk komposition
RU2084457C1 (ru) Способ получения l-карнозина и его гомологов
KR800001506B1 (ko) 이미다졸기 함유펩티드의 제조방법
KR850000844B1 (ko) 피롤리딘 유도체의 제조방법
KR810000610B1 (ko) 6-(m-아미노페닐)-2, 3, 5, 6-테트라하이드로 이미다조[2, 1-b] 티아졸 유도체의 제조방법
IE47354B1 (en) Substituted 2-aminomethylphenyl sulfamates,process for preparing,and pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8305157-3

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8305157-3

Format of ref document f/p: F